Examples
Hormone replacement therapy (HRT) refers to the use of
estrogen plus
progestin for the treatment of
perimenopausal symptoms. It is also commonly referred
to as "opposed estrogen therapy."
Estrogen and progestin combinations (pills or
tablets)
| Generic Name | Brand Name |
|---|
| conjugated estrogens/medroxyprogesterone | Premplus |
| estradiol/norethindrone acetate | FemHRT |
Transdermal combination preparations (a patch
placed on the skin that continuously releases estrogen and
progestin)
| Generic Name | Brand Name |
|---|
| estradiol/norethindrone acetate | Estracomb, Estalis, Estalis Sequi |
Oral progestin (pills or tablets; used along with
an estrogen-only preparation)
| Generic Name | Brand Name |
|---|
| medroxyprogesterone | Provera |
| micronized progesterone | Prometrium |
| norethindrone | Micronor, Norlutin |
Progestin intrauterine device (IUD; used along with
an estrogen-only preparation)
| Generic Name | Brand Name |
|---|
| levonorgestrel | Mirena |
Estrogen-progestin hormone therapy, or HRT, is recommended for all
women with a uterus who choose to take
estrogen. Using estrogen without
progestin greatly increases your risk of
endometrial cancer. Taking progestin with estrogen
eliminates this increased risk.1
How It Works
HRT increases the estrogen and progestin levels in your body. There
are several
standard hormone replacement therapy schedules,
including continuous and cyclic along with higher-dose and low-dose.
Combining
progestin with estrogen:
- Protects against
endometrial cancer (which can develop with
estrogen-only therapy).
- Is not needed for women who have no
uterus.
- May trigger monthly withdrawal bleeding when progestin is
used periodically (such as in cyclic HRT).
Patch warning. Direct sunlight or high heat
can increase, then lower, the amount of hormone released from a patch. This can
give you a big dose at the time and leave less hormone for the patch to release
later in the week. Avoid direct sunlight on the hormone
patch. Also avoid using a tanning bed, heating pad, electric blanket, hot tub,
or sauna while you are using a hormone patch.
Why It Is Used
The
estrogen in hormone therapy is used by some
post-menopausal women to increase estrogen levels. This helps prevent
osteoporosis and perimenopausal symptoms, such as hot
flashes and sleep problems.
But HRT slightly increases risks of some serious health problems.
This means that in a small number of women, HRT is known to cause breast
cancer, ovarian cancer, blood clots, or dementia. In women who are 10 or more
years past menopause, using HRT slightly raises the risk of
heart disease.2
The Society of Obstetricians and Gynaecologists of Canada (SOGC)
recommends HRT for:
- Short-term treatment of menopausal
symptoms, at the lowest effective dose for as short a time as possible.3
- Osteoporosis prevention and treatment, in select
cases. Most experts recommend that HRT only be considered for women with
significant risk of osteoporosis that may outweigh their risks of taking
HRT.4 Women are now encouraged to consider all
possible osteoporosis treatments and to compare their risks and
benefits.5 For more information, see the topic
Osteoporosis.
Who should not use HRT
You should not use HRT if you:
How Well It Works
HRT increases estrogen levels, which:6, 7
- Helps prevent post-menopausal osteoporosis by
slowing bone loss and promoting some increase in bone density.7
- Reduces hot flashes, depression, and sleep
problems in most, but not all, women.7, 8
- Maintains the lining of the vagina, reducing
irritation.
- Increases skin collagen levels, which drop as estrogen
levels naturally decrease. Collagen is responsible for the stretch in skin and
muscle.
- Reduces the risk of dental problems, such as tooth loss and
gum disease.
- May slightly lower the risk of colon cancer.6 (This is based on one study.)
Side Effects
Risks of hormone replacement therapy
Hormone replacement therapy was part of a large set of clinical
trials called the
Women's Health Initiative (WHI). The HRT portion of
these trials showed a small increase in the rate of
breast cancer among the women taking a combination of
0.625 mg of estrogen plus
2.5 mg of progestin daily. WHI data has also
shown an increased rate of cardiovascular disease and dementia with HRT
use.
- Within the first 2 years, HRT use slightly
increased the number of women with blood clots in the lungs (pulmonary embolism) and legs (deep vein
thrombosis). This risk increased in all healthy post-menopausal women,
regardless of risk factors.9
- During the
second year, HRT use began to slightly increase
heart attack and
stroke risk in all healthy post-menopausal women,
regardless of risk factors. Early signs of heart disease first became apparent
during the first year of use.9, 10 Heart disease risk may differ for younger menopausal
women.11, 12
- After
1 year, HRT use increased the number of abnormal
mammograms by approximately 4% per year. Daily
estrogen-progestin increased breast density compared with estrogen alone or
placebo. Although the abnormal mammograms required
additional medical evaluation, they were not linked to an early increase in
breast cancer. Studies are ongoing to learn more about breast density change
from HRT.13
- After 4 years of use,
HRT-related breast cancers first became apparent. The number of HRT-related
breast cancers increased with each additional year of HRT use. Women taking HRT
generally had larger, more advanced tumours than women who developed breast
cancer while taking placebo treatment.6 (Some of these
cancers, however, may respond more favourably to treatment.)14
- After 4 years, HRT use slightly increased the
incidence of
Alzheimer’s disease and other
dementias in women ages 65 and older. HRT does not
provide protection from dementia or
cognitive impairment, as was previously
believed.15 (Most of the women in this study started
HRT several years after menopause, when Alzheimer's risk naturally increases.
Therefore, experts do not yet know whether Alzheimer's risk is the same for
younger women who use short-term HRT starting at menopause.)
Experts do not yet know whether
lower-dose, shorter-term HRT reduces or eliminates
these risks.
Serious health events caused or prevented by
HRT, per 1,000 women (estrogen 0.625 mg plus progestin 2.5 mg):16| Health event | After 2 years of HRT use | After 5.2 years of HRT use |
|---|
| Blood clots (venous thromboembolism) | 6 more* | 9 more |
| Coronary artery disease | 3 more ** | 4 more |
| Breast cancer | No change*** | 4 more |
| Stroke | 1 more**** | 4 more |
| Colorectal cancer | No change | 3 fewer# |
| Hip fractures | 1 fewer | 2 fewer |
| Death | No change | No change |
* Risk is greatest during the first 2 years of
use. | ** Signs develop as early as the first year of
use. | *** First noted after 4 years of
use. | **** First noted after 1 year of
use. | # Benefit noted after 3 years of
use. |
|
These average increased risks are relatively low in the general
population of post-menopausal women. Your personal risk that hormone therapy
may stimulate breast cancer, cardiovascular problems, blood clots, or
neurological changes may be significantly lower or higher, depending on your
risk factors. Not all possible risk factors are known.
Estrogen side effects
Side effects that can occur with all forms of estrogen but are
more frequent with oral estrogen include:
- Irregular vaginal
bleeding.
- Headaches.
- Nausea.
- Vaginal
discharge.
- Fluid retention.
- Weight
gain.
- Breast tenderness.
- Spotting or darkening of the
skin, particularly on the face.
- Asthma. Newly
diagnosed asthma appears to be more common among women taking HRT or
estrogen-alone (ERT) than women who are not. (Estrogen is thought to be a
factor that causes or worsens asthma across the lifespan.)17
- Gallstones. Women who use estrogen
replacement therapy are more likely to have gallstones that cause symptoms than
women who do not use ERT. (High estrogen levels are linked to gallbladder
disease.)
- Rarely, an increased growth of pre-existing
uterine fibroids or a worsening of
endometriosis.
In addition, the estrogen patch (transdermal estrogen) may cause
skin irritation.
Some of these side effects, such as headaches, nausea, fluid
retention, weight gain, and breast tenderness, may go away after a few weeks of
use.
Progestin side effects
The side effects of progestin often cause women to stop using
hormone replacement therapy (HRT). Adjusting the progestin dose, changing the
dosing schedule, or changing the type of progestin may reduce side effects. The
progestin
intrauterine device (IUD) reduces or eliminates side
effects that are common with oral progestin.1
Progestin side effects include:
- Mood changes, such as anxiety, irritability,
or depression.
- Headache.
- Breast pain or
tenderness.
- Abdominal pain or bloating
(distention).
- Dizziness or
drowsiness.
- Diarrhea.
- Vaginal discharge.
Cyclic progestin (taken 10 to 14 days per
month) is more likely to cause:
- Premenstrual-like symptoms, such as bloating,
cramping, breast tenderness, nausea, and depression.
- Monthly
withdrawal bleeding.
The combination transdermal patch may cause
skin irritation.
See Drug Reference for a full list of side effects. (Drug Reference
is not available in all systems.)
What To Think About
If you have been taking HRT, talk with your health professional
about your reasons for taking it. Are you taking it to help with perimenopausal
symptoms or for long-term health reasons? Consider changing to another
treatment, depending on the problem you are using HRT to treat. If HRT seems
like the best choice for you, plan to use the lowest possible effective
dose.
If you are unable to tolerate the side effects of progestin in
hormone replacement therapy and you have not had a
hysterectomy, try non-hormonal treatment options.
Some women use estrogen-only therapy (ERT) if testing does not show
abnormalities of the lining of the uterus (endometrium).
However, because this greatly increases your risk of uterine cancer, health
professionals don't recommend taking estrogen alone. If you do take estrogen
without progestin, you must have regular checks for precancerous changes of the
endometrium. This means an annual
pelvic examination along with an annual endometrial
biopsy or transvaginal ultrasound.
The British Million Women Study has confirmed the Women's Health
Initiative findings and has provided
more information about estrogen, progestin, and breast and
endometrial cancers.18 This is important
information for women deciding whether to take estrogen without progestin, as
described above.
When given with a skin patch, estrogen-progestin enters the
bloodstream directly, without passing through the liver. The estrogen and
progestin in pills must be processed by the liver before entering the
bloodstream. This is why women with liver or gallbladder disease can usually
use a patch form of HRT.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.